{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:09:33Z","timestamp":1790388573777,"version":"4.1.0"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/cco.0000000000000243","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T18:33:52Z","timestamp":1449081232000},"page":"88-96","source":"Crossref","is-referenced-by-count":63,"title":["Tumor microenvironment in mycosis fungoides and S\u00e9zary syndrome"],"prefix":"10.1097","volume":"28","author":[{"given":"Belen Rubio","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Zain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-15-20210128","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"R3-15-20210128","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R4-15-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1468-3083.2004.00937.x","article-title":"Clinicopathological spectrum of mycosis fungoides.","volume":"18","author":"Kazakov","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R5-15-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07526.x","article-title":"Mycosis fungoides: a dermatological masquerader.","volume":"156","author":"Nashan","year":"2007","journal-title":"Br J Dermatol"},{"key":"R6-15-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R7-15-20210128","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","article-title":"Mast cells play a protumorigenic role in primary cutaneous lymphoma.","volume":"120","author":"Rabenhorst","year":"2012","journal-title":"Blood"},{"key":"R8-15-20210128","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/jid.2014.206","article-title":"Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.","volume":"134","author":"Wu","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R9-15-20210128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","article-title":"Association of the numbers of CD163() cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.","volume":"68","author":"Sugaya","year":"2012","journal-title":"J Dermatol Sci"},{"key":"R10-15-20210128","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1200\/JCO.2001.19.23.4322","article-title":"CD8 T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.","volume":"19","author":"Vermeer","year":"2001","journal-title":"J Clin Oncol"},{"key":"R11-15-20210128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumor microenvironment biology: challenges and opportunities.","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med"},{"key":"R12-15-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1346-8138.12305","article-title":"Immunological milieu in mycosis fungoides and Sezary syndrome.","volume":"41","author":"Miyagaki","year":"2014","journal-title":"J Dermatol"},{"key":"R13-15-20210128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1309\/AJCP7LRRLK8SLUGE","article-title":"Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.","volume":"134","author":"Kelemen","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R14-15-20210128","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1182\/blood.V83.9.2580.2580","article-title":"T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28.","volume":"83","author":"Nickoloff","year":"1994","journal-title":"Blood"},{"key":"R15-15-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/1523-1747.ep12363352","article-title":"HLA-DR5 and DQB103 class II alleles are associated with cutaneous T-cell lymphoma.","volume":"107","author":"Jackow","year":"1996","journal-title":"J Invest Dermatol"},{"key":"R16-15-20210128","first-page":"636","article-title":"Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).","volume":"16","author":"Jarrousse","year":"2006","journal-title":"Eur J Dermatol"},{"key":"R17-15-20210128","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1468-3083.2011.04049.x","article-title":"Toll-like receptors and skin.","volume":"25","author":"Ermertcan","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R18-15-20210128","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-4632.2010.04763.x","article-title":"Contact hypersensitivity in patients with primary cutaneous lymphoproliferative disorders.","volume":"50","author":"Khamaysi","year":"2011","journal-title":"Int J Dermatol"},{"key":"R19-15-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0536.1976.tb03012.x","article-title":"Lymphomatoid contact dermatitis: a syndrome produced by epicutaneous hypersensitivity with clinical features and a histopathologic picture similar to that of mycosis fungoides.","volume":"2","author":"Orbaneja","year":"1976","journal-title":"Contact Dermatitis"},{"key":"R20-15-20210128","doi-asserted-by":"crossref","first-page":"799","DOI":"10.5301\/ijao.5000030","article-title":"Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus.","volume":"34","author":"Pietrocola","year":"2011","journal-title":"Int J Artif Organs"},{"key":"R21-15-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V89.1.32","article-title":"Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.","volume":"89","author":"Jackow","year":"1997","journal-title":"Blood"},{"key":"R22-15-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2008.08612.x","article-title":"Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sezary syndrome.","volume":"159","author":"Talpur","year":"2008","journal-title":"Br J Dermatol"},{"key":"R23-15-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1523-1747.ep12494184","article-title":"Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins.","volume":"98","author":"Tokura","year":"1992","journal-title":"J Invest Dermatol"},{"key":"R24-15-20210128","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"R25-15-20210128","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain).","volume":"88","author":"Dummer","year":"1996","journal-title":"Blood"},{"key":"R26-15-20210128","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/jid.2011.27","article-title":"Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3Stat3 signaling pathway.","volume":"131","author":"Krejsgaard","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R27-15-20210128","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","article-title":"TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.","volume":"19","author":"Guenova","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R28-15-20210128","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1158\/1078-0432.CCR-14-0707","article-title":"Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.","volume":"20","author":"Wolk","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R29-15-20210128","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.pas.0000213267.92349.59","article-title":"Chemokine receptor expression in cutaneous T cell and NKT-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.","volume":"30","author":"Yagi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R30-15-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1523-1747.ep12388985","article-title":"Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.","volume":"103","author":"Saed","year":"1994","journal-title":"J Invest Dermatol"},{"key":"R31-15-20210128","doi-asserted-by":"crossref","first-page":"117ra7","DOI":"10.1126\/scitranslmed.3003008","article-title":"Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.","volume":"4","author":"Clark","year":"2012","journal-title":"Sci Transl Med"},{"key":"R32-15-20210128","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors.","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"R33-15-20210128","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.194.10.1541","article-title":"CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.","volume":"194","author":"Reiss","year":"2001","journal-title":"J Exp Med"},{"key":"R34-15-20210128","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma.","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R35-15-20210128","first-page":"7","article-title":"T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion.","volume":"1-","author":"Yang","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R36-15-20210128","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1046\/j.1523-1747.2003.12555.x","article-title":"Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides.","volume":"121","author":"Kallinich","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R37-15-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","article-title":"The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.","volume":"115","author":"Lu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R38-15-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/2277-9175.108770","article-title":"CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4 lymphocytes in gastric cancer patients.","volume":"2","author":"Andalib","year":"2013","journal-title":"Adv Biomed Res"},{"key":"R39-15-20210128","first-page":"1","article-title":"Expression of chemokine receptors on Th1Th2 CD4 lymphocytes in patients with multiple sclerosis.","volume":"8","author":"Andalib","year":"2011","journal-title":"Iran J Immunol"},{"key":"R40-15-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2004.03.002","article-title":"Chemokine receptors and melanoma metastasis.","volume":"36","author":"Murakami","year":"2004","journal-title":"J Dermatol Sci"},{"key":"R41-15-20210128","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","article-title":"Circulating clonal CLA() and CD4() T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.","volume":"152","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Br J Dermatol"},{"key":"R42-15-20210128","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.","volume":"18","author":"Sommer","year":"2004","journal-title":"Leukemia"},{"key":"R43-15-20210128","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.leu.2401415","article-title":"Inhibition of constitutively activated Stat3 correlates with altered Bcl-2Bax expression and induction of apoptosis in mycosis fungoides tumor cells.","volume":"13","author":"Nielsen","year":"1999","journal-title":"Leukemia"},{"key":"R44-15-20210128","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaad.2006.08.067","article-title":"Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sezary syndrome.","volume":"56","author":"Querfeld","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R45-15-20210128","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.jid.5700122","article-title":"CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma.","volume":"126","author":"Talpur","year":"2006","journal-title":"J Invest Dermatol"},{"key":"R46-15-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/leu.2011.237","article-title":"Regulatory T cells and immunodeficiency in mycosis fungoides and Sezary syndrome.","volume":"26","author":"Krejsgaard","year":"2012","journal-title":"Leukemia"},{"key":"R47-15-20210128","first-page":"2682","article-title":"Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8 cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape Clin Cancer R","volume":"7","author":"Ni","year":"2001","journal-title":"es"},{"key":"R48-15-20210128","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3 regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"key":"R49-15-20210128","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.4049\/jimmunol.181.4.2506","article-title":"Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4 T lymphocytes.","volume":"181","author":"Kasprzycka","year":"2008","journal-title":"J Immunol"},{"key":"R50-15-20210128","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function.","volume":"188","author":"Zajac","year":"1998","journal-title":"J Exp Med"},{"key":"R51-15-20210128","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood-2008-09-179697","article-title":"Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.","volume":"114","author":"Mumprecht","year":"2009","journal-title":"Blood"},{"key":"R52-15-20210128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"R54-15-20210128","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1365-2133.2000.03889.x","article-title":"Decreased expression of Fas (APO-1CD95) on peripheral blood CD4 T lymphocytes in cutaneous T-cell lymphomas.","volume":"143","author":"Dereure","year":"2000","journal-title":"Br J Dermatol"},{"key":"R55-15-20210128","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.","volume":"118","author":"Dereure","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R56-15-20210128","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/jid.2009.301","article-title":"Downregulation of Fas gene expression in Sezary syndrome is associated with promoter hypermethylation.","volume":"130","author":"Jones","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R57-15-20210128","first-page":"5389","article-title":"A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma.","volume":"62","author":"van Doorn","year":"2002","journal-title":"Cancer Res"},{"key":"R58-15-20210128","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FASCD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R59-15-20210128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.0906-6705.2004.00176.x","article-title":"Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma.","volume":"13","author":"Rubben","year":"2004","journal-title":"Exp Dermatol"},{"key":"R60-15-20210128","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2002-08-2434","article-title":"Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.","volume":"101","author":"Mao","year":"2003","journal-title":"Blood"},{"key":"R61-15-20210128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.0022-202x.2001.01682.x","article-title":"Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome.","volume":"118","author":"Scarisbrick","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R62-15-20210128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.196","article-title":"CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.","volume":"23","author":"Laharanne","year":"2010","journal-title":"Mod Pathol"},{"key":"R63-15-20210128","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","article-title":"Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.","volume":"23","author":"van Doorn","year":"2005","journal-title":"J Clin Oncol"},{"key":"R64-15-20210128","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V95.9.2937.009k15_2937_2942","article-title":"Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN.","volume":"95","author":"Scarisbrick","year":"2000","journal-title":"Blood"},{"key":"R65-15-20210128","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2133.2002.04966.x","article-title":"Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides.","volume":"147","author":"Mao","year":"2002","journal-title":"Br J Dermatol"},{"key":"R66-15-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jcp.56.6.453","article-title":"Density of neoplastic lymphoid infiltrate, CD8 T cells, and CD1a dendritic cells in mycosis fungoides.","volume":"56","author":"Goteri","year":"2003","journal-title":"J Clin Pathol"},{"key":"R67-15-20210128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","article-title":"CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides.","volume":"32","author":"Hoppe","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R68-15-20210128","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","article-title":"The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells.","volume":"99","author":"Berger","year":"2002","journal-title":"Blood"},{"key":"R69-15-20210128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.jid.5700029","article-title":"Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides: cutaneous T cell lymphoma.","volume":"126","author":"Wong","year":"2006","journal-title":"J Invest Dermatol"},{"key":"R70-15-20210128","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1476-5381.2010.00961.x","article-title":"Histamine receptors and cancer pharmacology.","volume":"161","author":"Medina","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R71-15-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm0111-43","article-title":"Histamine restricts cancer: nothing to sneeze at.","volume":"17","author":"Ruffell","year":"2011","journal-title":"Nat Med"},{"key":"R72-15-20210128","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1189\/jlb.0705358","article-title":"Interleukin-10 and the immune response against cancer: a counterpoint.","volume":"78","author":"Mocellin","year":"2005","journal-title":"J Leukoc Biol"},{"key":"R73-15-20210128","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ced.12404","article-title":"Transforming growth factor-beta1 gene polymorphism in mycosis fungoides.","volume":"39","author":"Zayed","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"R74-15-20210128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","article-title":"Interleukin-15 is an autocrineparacrine viability factor for cutaneous T-cell lymphoma cells.","volume":"92","author":"Dobbeling","year":"1998","journal-title":"Blood"},{"key":"R75-15-20210128","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is over-expressed in cutaneous T-cell lymphoma cells and regulates their proliferation.","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"key":"R76-15-20210128","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1158\/0008-5472.CAN-07-2403","article-title":"Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4 cutaneous T-cell lymphoma cells.","volume":"68","author":"Marzec","year":"2008","journal-title":"Cancer Res"},{"key":"R78-15-20210128","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/leu.2015.105","article-title":"The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3KAKTS6 pathway and promotes apoptosis in CLL.","volume":"29","author":"Balakrishnan","year":"2015","journal-title":"Leukemia"},{"key":"R79-15-20210128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","article-title":"Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anticc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.","volume":"32","author":"Ogura","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:58:33Z","timestamp":1620950313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201601000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000243","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}